From: Is there a role for oral misoprostol in labor induction for prelabor rupture of membranes at term?
 | Oral Misoprostol (n = 493) | IV Oxytocin (n = 296) | Odds Ratio 95% CI | p-value |
---|---|---|---|---|
Neonatal birthweight (mean, s.d.grams) | 3240 ± 411.9 | 3277 ± 401 | N/A | 0.3 |
Macrosomia (n,%) | 20(4%) | 12 (4%) | 1 (0.5–2.1) | 0.5 |
APGAR < 7 at 5 min (n,%) | 1 (0.2%) | 0 | N/A | N/A |
Umbilical artery pH < 7.1 (n,%) | 1 (0.2%) | 1 (0.31%) | 0.6 (0.03–9.2) | 0.4 |
NICU Admission (n,%) | 0 | 0 | N/A | N/A |
Respiratory Morbidity (n,%) | 4 (0.81%) | 4 (1.4%) | 0.6 (0.1–2.4) | 0.2 |
Sepsis (n,%) | 0 | 0 | N/A | N/A |
Early-onset GBS disease (n,%) | 0 | 0 | N/A | N/A |
Hypoglycemia (n,%) | 0 | 1 (0.31%) | N/A | N/A |
Jaundice (n,%) | 0 | 1 (0.31%) | N/A | N/A |
Necrotizing enterocolitis (n,%) | 0 | 0 | N/A | N/A |
Composite neonatal outcome (n,%) | 6 (1.2%) | 7 (2.3%) | 0.9 (0.2–3.1) | 0.4 |